Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EntreMed Inc    

ENTREMED INC
Mes dernières consult.
Most popular
Report
SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops pharmaceutical drugs for treating cancer and inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD572012Chief Executive Officer & Director
Wei-Wu He PhD, MBA522012Executive Chairman
Cynthia Wong Hu472006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA502011Chief Accounting Officer & Vice President-Finance
Alexander A. Zukiwski, MD592017Chief Medical Officer
Zuie Chin Huang, MBA512013Independent Director
Yue Wu PhD, MBA532013Independent Director
Franklin Cary Salisbury, Jr.612014Independent Director
Rajesh C. Shrotriya, MD732014Independent Director
Quan Zhou, PhD592016Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 65,146,109 36,553,279 56.1% 79,545 0.1% 56.1%
Shareholders
NameEquities%
Spectrum Pharmaceuticals, Inc. 10,028,579 14.7%
Hexie Aiqi Investment Management Beijing Co., Ltd. 8,498,765 12.5%
IDG Capital Partners Co., Ltd. 5,452,385 8.00%
Zhejiang Kanglaite Group Co. Ltd. 4,938,269 7.25%
Emerging Technology Partners LLC 2,312,677 3.39%
Wei-Wu He PhD, MBA 847,527 1.24%
Wellington Shields Capital Management LLC 725,348 1.06%
Wellington Shields & Co. LLC (Investment Management) 489,984 0.72%
The Vanguard Group, Inc. 345,498 0.51%
European & Global Advisers LLP 343,500 0.50%
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
ENTREMED INC223
CELLTRION, INC.--.--%24 927
IQVIA HOLDINGS INC36.69%21 966
INCYTE CORPORATION-1.27%20 893
LONZA GROUP59.27%19 720
ALNYLAM PHARMACEUTICALS, INC.253.45%13 012
SEATTLE GENETICS, INC.12.05%8 510
NEKTAR THERAPEUTICS305.46%7 834
ALKERMES PLC-9.78%7 711
QIAGEN NV9.53%7 357
EXACT SCIENCES CORPORATION342.89%7 084
IONIS PHARMACEUTICALS INC13.61%6 757
ICON PLC57.38%6 396
UNITED THERAPEUTICS CORPORATION-12.56%5 419
PRA HEALTH SCIENCES INC51.20%5 281
BIO-TECHNE CORP28.79%4 961
CHARLES RIVER LABORATORIES INTL. INC34.26%4 845
GALAPAGOS27.22%4 675
INC RESEARCH HOLDINGS INC-28.52%3 923
SAGE THERAPEUTICS INC86.92%3 918
FIBROGEN INC121.26%3 883
Connections : EntreMed Inc
Spectrum Pharmaceuticals Cayman LP
Emerging Technology Partners LLC
American-Sino OB/GYN Hospital
CVie Therapeutics Co. Ltd.
IDG Capital Partners Co., Ltd.
Zenesis Ltd.
Wuhan Kindstar Diagnostics Co., Ltd.
OMNI Pharmaceuticals (USA), Inc.
OriGene Technologies, Inc.
Smooth Prosper Ltd.
Circle Internet Financial Ltd.
GenScript Corp.
Superdata Software Holdings Ltd.
KPCB China Fund II LP
Cs Family Trust
Human Longevity, Inc.
Beijing Genetron Biotechnology Co. Ltd.
National Foundation for Cancer Research
MithraGen, Inc.
IDG Technology Venture Investment III LLC
WUPIMA, Inc.
Intradigm Corp.
Creditease Holdings Cayman Ltd.
The UNLV Foundation
MZ Investment Holdings Ltd.
Shrotriya Family Foundation
IDG Technology Venture Investments LP
Allos Therapeutics, Inc.
IDG Technology Venture Investment IV LLC
© 2017 People , Fundamentals and Ownership